![Michael Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Kelly
Directeur Technique/Scientifique/R&D chez
CureDuchenne
Profil
Michael G.
Kelly is currently the Director at Trinds LLC since 2017 and the Chief Scientific Officer at CureDuchenne since 2011.
Previously, he worked as the President, Chief Executive Officer & Director at MyoTherix, Inc. He was also the Research Director at Amgen, Inc. from 1999 to 2000.
Additionally, he worked as a Director at NeoGenesis Pharmaceuticals, Inc. and as the Senior Vice President-Research & Development at Renovis, Inc. Dr. Kelly holds a doctorate degree from The University of Southampton and an undergraduate degree from the University of Ulster.
Postes actifs de Michael Kelly
| Sociétés | Poste | Début |
|---|---|---|
CureDuchenne
 CureDuchenne Financial ConglomeratesFinance Provides funding for research projects | Directeur Technique/Scientifique/R&D | 13/12/2011 |
Trinds LLC
 Trinds LLC Miscellaneous Commercial ServicesCommercial Services Operates as a research organization for neuromuscular diseases | Directeur/Membre du Conseil | 01/11/2017 |
Anciens postes connus de Michael Kelly
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/01/2000 |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Technique/Scientifique/R&D | - |
NeoGenesis Pharmaceuticals, Inc.
 NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Used to discover and develop small molecule drugs | Directeur/Membre du Conseil | - |
MyoTherix, Inc.
 MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies | Directeur Général | - |
Formation de Michael Kelly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
42
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Used to discover and develop small molecule drugs | Health Technology |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Ulster
 University of Ulster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance Provides funding for research projects | Finance |
MyoTherix, Inc.
MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies | Health Technology |
Trinds LLC
Trinds LLC Miscellaneous Commercial ServicesCommercial Services Operates as a research organization for neuromuscular diseases | Commercial Services |
Choisissez Zonebourse 
